$13.21-0.01 (-0.08%)
Cross Country Healthcare, Inc.
Cross Country Healthcare, Inc. in the Healthcare sector is trading at $13.21 with a market capitalization of $409M. Wall Street consensus targets $12.60 (5 analysts), implying a -4.6% move over the next 12 months. The stock is currently 12% below its 52-week high of $14.99, remaining 22.7% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $241.06M↑ | $236.76M↓ | $250.05M↓ | $274.07M↓ | $293.41M |
| Gross Profit | $47.59M↓ | $47.98M↓ | $50.93M↓ | $56.00M↓ | $58.66M |
| Operating Income | -$1.89M↑ | -$7.10M↓ | -$55,000↓ | $1.85M↑ | $1.40M |
| Net Income | -$4.27M↑ | -$82.93M↓ | -$4.77M↑ | -$6.66M↓ | -$490,000 |
Cross Country Healthcare, Inc. provides talent management services for healthcare clients in the United States. The company operates in two segments: Nurse and Allied Staffing, and Physician Staffing. The Nurse and Allied Staffing segment provides tr...
The deal comes months after an acquisition by travel nursing agency Aya Healthcare collapsed.
Cross Country (CCRN) delivered earnings and revenue surprises of +36.84% and +2.34%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
While the top- and bottom-line numbers for Cross Country (CCRN) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
DLH (DLHC) delivered earnings and revenue surprises of -6.25% and +2.18%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Cross Country Healthcare is back in focus after analysts reset price targets into the US$10 to US$14 range, while modelled fair value sits at US$11.67 per share. The new targets are being framed around the company’s margin ambitions through 2026 and the role of travel nurse demand in supporting higher margin segments, rather than short term trading swings. Read on to see what is driving the bullish and bearish narratives and how to keep track as the story develops. Stay updated as the Fair...